These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2612579)

  • 1. Discriminative stimulus effects of enkephalin analogs, EK-209 and EK-399, in rats.
    Nishida N; Hasegawa Y; Chiba S; Wakimasu M; Fujino M
    Eur J Pharmacol; 1989 Dec; 174(1):71-6. PubMed ID: 2612579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinforcing effects of the enkephalin analogs, EK-209 and EK-399, in rats.
    Nishida N; Hasegawa Y; Chiba S; Wakimasu M; Fujino M
    Eur J Pharmacol; 1989 Aug; 166(3):453-8. PubMed ID: 2806371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the discriminative stimulus effect of an enkephalin analog, EK-399, in the rat].
    Nishida N; Yasuhara Y; Chiba S
    Nihon Yakurigaku Zasshi; 1991 Jun; 97(6):361-9. PubMed ID: 1651892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Ala2,D-Leu5-enkephalin generalizes to a discriminative stimulus produced by fentanyl but not ethylketocyclazocine.
    Shearman GT; Herz A
    Pharmacol Biochem Behav; 1982 Feb; 16(2):249-52. PubMed ID: 6280202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical dependence potential of an enkephalin analog, EK-399, in rats.
    Nishida N
    Jpn J Pharmacol; 1990 Aug; 53(4):443-50. PubMed ID: 2214369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the receptor subtypes mediating the analgesic action of an enkephalin analog, Tyr-D-Met(O)-Gly-EtPhe-NHNHCOCH3.AcOH (EK-399).
    Doi T; Kuzuna S; Fujino M
    Jpn J Pharmacol; 1988 Aug; 47(4):409-15. PubMed ID: 2846934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous self-administration of an enkephalin analog, EK-399, by rats.
    Nishida N; Chiba S
    J Toxicol Sci; 1991 May; 16(2):75-86. PubMed ID: 1886174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.
    Paronis CA; Holtzman SG
    Psychopharmacology (Berl); 1994 May; 114(4):601-10. PubMed ID: 7855222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drug-induced differences in reinforcement frequency on discriminative stimulus properties of fentanyl.
    De Vry J; Koek W; Slangen JL
    Psychopharmacology (Berl); 1984; 83(3):257-61. PubMed ID: 6433387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat.
    Shearman GT; Herz A
    Eur J Pharmacol; 1982 Aug; 82(3-4):167-72. PubMed ID: 6290235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evaluation of the discriminative effects of morphine in the rat.
    Shannon HE; Holtzman SG
    J Pharmacol Exp Ther; 1977 Apr; 201(1):55-66. PubMed ID: 15104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of fentanyl and morphine: tolerance and dependence.
    Colpaert FC; Kuyps JJ; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1976 Oct; 5(4):401-8. PubMed ID: 12518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the stimulus effects of codeine in rhesus monkeys under the contingencies of a two lever discrimination task and a cross self-administration paradigm: tests of generalization to pentazocine, buprenorphine, tilidine, and different doses of codeine.
    Hoffmeister F
    Psychopharmacology (Berl); 1988; 94(3):315-20. PubMed ID: 3128807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination.
    Colpaert FC; Janssen PA
    Psychopharmacology (Berl); 1986; 90(2):222-8. PubMed ID: 3097702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentazocine, cyclazocine, and nalorphine as discriminative stimuli.
    Hirschhorn ID
    Psychopharmacology (Berl); 1977 Nov; 54(3):289-94. PubMed ID: 413147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discriminative stimulus properties of cyclazocine: generalization studies involving nalorphine, morphine and LSD.
    Rosecrans JA; Chance WT; Spencer RM
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):221-37. PubMed ID: 674812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of bradykinin-induced nociception in the rat as a test for analgesic drugs with particular reference to morphine antagonists.
    Blane GF
    J Pharm Pharmacol; 1967 Jun; 19(6):367-73. PubMed ID: 4382365
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions between H1-antagonists and opioids: a drug discrimination study.
    Suzuki T; Mori T; Tsuji M; Misawa M; Onodera K
    Psychopharmacology (Berl); 1997 Jun; 131(4):346-53. PubMed ID: 9226736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.